Vassiliou et al., using endothelial biomarkers in hospitalised patients with COVID-19 admitted to the ICU, found that elevation of sE-selectin, sP-selectin, Ang-2, and sICAM-1 levels were significantly elevated in ICU non-survivors compared to survivors, with a higher mortality probability. This evidence concerns the gene ANGPT2 and COVID-19.